arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Aclaris Therapeutics, Inc.

ACRS

$3.63 ▼ -0.04 (-1.09%) at close

14 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Aclaris Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $444.9M

Dividend Yield —

Revenue Growth -58.2% ↘

Op. Margin None

ROIC -58.5% ↗

FCF / Share $-0.39 ↘

Trailing P/E —

Price / Book 4.2x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

14-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$7.83M

↓ -58.2% —

Net Income Profit after all expenses

$-64.92M

↑ +50.8% —

Operating Margin Operating profit as % of sales

-311.6%

↓ -3.2% —

FCF / Share Free cash flow per share

$-0.39

↓ -47.5% —

Long-Term Debt Long-term obligations

$10.65M

↓ -64.4% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Revenue Growth YoY (%)	-58.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-827%)	-40.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-601%)	5.0% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-37%)	340.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4151%)	4.3% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-46%)	53.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+567%)	-31.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-491%)	265.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3218%)	—	—	—	—	—	—
EPS Growth YoY (%)	69.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-34.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	4.5% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	16.9% Good Good Year-over-year change in earnings per share Optimal: > 10%	-33.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	50.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-49.3% Weak ↓ Weak Declining Year-over-year change in net income	-1.8% Weak → Weak Stable Year-over-year change in net income	4.4% Caution ↑ Caution Improving Year-over-year change in net income	-78.1% Weak ↓ Weak Declining Year-over-year change in net income	68.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-21.6% Weak ↑ Weak Improving Year-over-year change in net income	-93.7% Weak ↑ Weak Improving Year-over-year change in net income	-42.5% Weak ↑ Weak Improving Year-over-year change in net income	-133.8% Weak ↓ Weak Declining Year-over-year change in net income	-141.4% Weak Weak Year-over-year change in net income	-62.7% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-47.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	77.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-9.1% Weak ↓ Weak Declining Year-over-year change in free cash flow	-13.1% Weak Weak Year-over-year change in free cash flow	-0.6% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-35.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	40.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	68.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	91.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	3.2% Caution Caution Compound annual revenue growth over 3 years	56.8% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	3.8% Caution ↓ Caution Declining Compound annual revenue growth over 5 years	34.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	38.4% Excellent Excellent Compound annual revenue growth over 5 years	77.6% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Operating Margin (%) (%)	—	—	-311.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2177%)	-302.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2113%)	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	2.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—
Profit Margin (%) (%)	—	—	-283.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2460%)	-292.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2534%)	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	-107.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-254.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-229.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.73x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.15x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Return on Invested Capital (%)	-58.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-72.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-61.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-35.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-35.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-105.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-125.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-31.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-22.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	32.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	45.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-47.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-64.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-49.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-35.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-35.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-71.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-113.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-30.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-49.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-63.0% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-520%)	-84.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-666%)	-56.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-475%)	-44.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-393%)	-46.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-407%)	-135.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1003%)	-230.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1639%)	-61.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-511%)	-30.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-303%)	-28.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-289%)	-22.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-248%)	41.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+174%)	57.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+281%)	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Debt to Equity (x)	—	—	—	—	—	0.28x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-53%)	—	0.14x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-77%)	—	—	—	—	—	—
Net Debt (USD)	$-19.96M	$-24.57M	$-39.88M	$-45.28M	$-27.35M	$-11.41M	$-34.19M	$29.91M	$-20.20M	$-30.17M	$-9.85M	$-10.76M	$-9.59M	$-19.04M
Debt / EBITDA (x)	—	—	—	—	—	-0.21x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.36x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Revenue per Share (USD)	$0.06	$0.24	$0.45	$0.46	$0.12	$0.15	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.53	$-1.71	$-1.27	$-1.33	$-1.60	$-1.20	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.39	$-0.26	$-1.14	$-1.05	$-0.92	$-0.92	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.86	$1.44	$2.22	$2.96	$3.22	$0.83	$1.69	$5.22	$7.31	$6.50	$4.59	$-7.60	—	—
Tangible Book Value per Share (USD)	$0.86	$1.44	$2.21	$2.86	$3.11	$0.68	$1.51	$4.59	$6.47	$6.50	$4.59	$-7.60	—	—
Basic Weighted Avg Shares (shares)	122.56M	77.30M	69.81M	65.21M	56.73M	42.54M	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Working Capital (USD)	$67.67M	$94.36M	$97.90M	$209.61M	$182.10M	$42.62M	$61.37M	$152.16M	$187.46M	$132.33M	$84.97M	$14.88M	—	—
LT Debt (USD)	—	—	—	—	—	$10.65M	—	$29.91M	—	—	—	—	—	—
Total Equity (USD)	$103.08M	$155.55M	$157.18M	$197.62M	$197.34M	$37.65M	$69.91M	$215.12M	$225.26M	$169.49M	$92.52M	$-20.75M	$-9.16M	$-2.19M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Sales/Revenue/Turnover (USD)	$7.83M	$18.72M	$31.25M	$29.75M	$6.76M	$6.48M	$4.23M	$6.15M	$1.68M	—	—	—	—	—
Depreciation Expense (USD)	$454.00K	$807.00K	$863.00K	$797.00K	$923.00K	$1.32M	$6.41M	$1.88M	$402.00K	$120.00K	$90.00K	$12.00K	$11.00K	—
Net Income, GAAP (USD)	$-64.92M	$-132.06M	$-88.48M	$-86.91M	$-90.86M	$-51.02M	$-161.35M	$-132.74M	$-68.52M	$-48.08M	$-20.56M	$-8.52M	$-5.24M	—
Operating Cash Flow (USD)	$-47.11M	$-20.07M	$-78.33M	$-67.57M	$-52.13M	$-38.63M	$-96.44M	$-100.81M	$-54.66M	$-34.60M	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 14 years · 51 quarters

Aclaris Therapeutics, Inc.

Analytical Summary

14-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ACRS with peers